Support Hours: M-F
9AM-6PM EST
Patient Login
WHAT IS
PT - 141?
Bremelanotide, or PT-141 as it’s becoming increasingly known as, is an analog of alpha-melanocyte-stimulating hormone which then acts at the melanocortin-4 receptors in your central nervous system. It’s a quite an effective treatment for erectile dysfunction and stimulating female arousal. Bremelanotide (PT-141) is the first FDA approved peptide for sexual enhancement.
The latter is the most pronounced effect increasing both men and women’s libidos and sexual gratification. Men will experience substantially stronger and longer lasting erections. PT-141 is ideal for those with erectile dysfunction or those simply wishing to improve sexual performance.
Try it now,
Thanks us later!
HOW PT - 141
WORKS
Unlike Viagra and other related medications, it does not act upon the vascular system, but directly increases sexual desire via the nervous system. PT 141 provides stimulation to your central nervous system that increases sexual responses by activating and boosting dopamine production.
Top Benefits:
- - Increased libido in both men and women.
- - Instant erectile response.
- - Instant sexual arousal in women.
- - Boosted energy levels.
- - No negative vascular side effects.
Life Is Too Short
For Bad Sex,
Have Fun Again!
Safety Information
Side effects
The most common side effect is nausea which appears to be dose dependent. Other less common side effects include headache and upset stomach and a potential acute rise in cortisol. Before increasing your dose, consult with your physician.
Dosages
PT-141 is typically taken sublingually (under the tongue), 2-4 hours prior to sexual activity. Dosages may vary as directed by your physician.
SOURCES
- - BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.
- - The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival and cell migration
- - Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression
- - https://josr-online.biomedcentral.com/articles/10.1186/s13018-019-1242-6